T. Rowe Price Associates
BIND

T. Rowe Price Associates’s BIND THERAPEUTICS INC BIND Stock Holding History

T. Rowe Price Associates’s Portfolio BIND Stock Details BIND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-28,042
Closed -$154K – 2614
2015
Q1 		$154K Sell
28,042
-13,816
-33% -$84.9K ﹤0.01% 2414
2014
Q4 		$226K Sell
41,858
-23,267
-36% -$174K ﹤0.01% 2308
2014
Q3 		$559K Buy
+65,125
New +$642K ﹤0.01% 1892

Other funds holding BIND

PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 39.77% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

T. Rowe Price Associates's BIND Position: Q2 2015 in Review

T. Rowe Price Associates sold out of BIND THERAPEUTICS INC (BIND) in Q2 2015, closing a stake of 28,042 shares — an estimated $154K sold.

T. Rowe Price Associates first reported a position in BIND in Q3 2014 and held it in 3 quarters. The position peaked at $559K in Q3 2014. 36 funds tracked by Wall St. Rank hold BIND as of Q2 2015.

  • T. Rowe Price Associates reported no remaining BIND THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • T. Rowe Price Associates sold 28,042 BIND THERAPEUTICS INC shares in Q2 2015, an estimated $154K.
  • T. Rowe Price Associates first reported a position in BIND THERAPEUTICS INC in Q3 2014 and held it in 3 quarters.
  • T. Rowe Price Associates's BIND THERAPEUTICS INC position peaked at $559K in Q3 2014.
  • 36 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q2 2015.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.